215 related articles for article (PubMed ID: 20650309)
21. [The anti-tumor efforts of thymosin alpha1 on tumor lysate-pulsed dendritic cells in colon cancer in vitro and in vivo].
Ma YL; Zheng Z; Li BD; Xie SJ; Li GX; Yan QH; Cai JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1046-9. PubMed ID: 17988589
[TBL] [Abstract][Full Text] [Related]
22. Biodegradable injectable in situ implants and microparticles for sustained release of montelukast: in vitro release, pharmacokinetics, and stability.
Ahmed TA; Ibrahim HM; Samy AM; Kaseem A; Nutan MT; Hussain MD
AAPS PharmSciTech; 2014 Jun; 15(3):772-80. PubMed ID: 24648158
[TBL] [Abstract][Full Text] [Related]
23. Development of biodegradable in situ implant and microparticle injectable formulations for sustained delivery of haloperidol.
Ahmed TA; Ibrahim HM; Ibrahim F; Samy AM; Kaseem A; Nutan MT; Hussain MD
J Pharm Sci; 2012 Oct; 101(10):3753-62. PubMed ID: 22753324
[TBL] [Abstract][Full Text] [Related]
24. Concomitant monitoring of implant formation and drug release of in situ forming poly (lactide-co-glycolide acid) implants in a hydrogel matrix mimicking the subcutis using UV-vis imaging.
Sun Y; Jensen H; Petersen NJ; Larsen SW; Østergaard J
J Pharm Biomed Anal; 2018 Feb; 150():95-106. PubMed ID: 29216591
[TBL] [Abstract][Full Text] [Related]
25. Immunomodulatory function of orally administered thymosin alpha1.
Chen XM; Jiang HL; Zhou LF; Pan XP; Hu ZR; Liu RH; Chen XM; Chen Z
J Zhejiang Univ Sci B; 2005 Sep; 6(9):873-6. PubMed ID: 16130188
[TBL] [Abstract][Full Text] [Related]
26. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
Chaw CS; Yang YY; Lim IJ; Phan TT
J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
[TBL] [Abstract][Full Text] [Related]
27. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
[TBL] [Abstract][Full Text] [Related]
28. Sustained release of bee venom peptide from biodegradable thermosensitive PLGA-PEG-PLGA triblock copolymer-based hydrogels in vitro.
Qiao M; Chen D; Ma X; Hu H
Pharmazie; 2006 Mar; 61(3):199-202. PubMed ID: 16599259
[TBL] [Abstract][Full Text] [Related]
29. The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide and its binding to TLR2.
Li J; Cheng Y; Zhang X; Zheng L; Han Z; Li P; Xiao Y; Zhang Q; Wang F
Cancer Lett; 2013 Sep; 337(2):237-47. PubMed ID: 23684552
[TBL] [Abstract][Full Text] [Related]
30. A novel injectable in situ forming poly-DL-lactide and DL-lactide/glycolide implant containing lipospheres for controlled drug delivery.
Yehia SA; Elshafeey AH; Elsayed I
J Liposome Res; 2012 Jun; 22(2):128-38. PubMed ID: 22091557
[TBL] [Abstract][Full Text] [Related]
31. Bioactivity and pharmacokinetics of two human serum albumin-thymosin alpha1-fusion proteins, rHSA-Talpha1 and rHSA-L-Talpha1, expressed in recombinant Pichia pastoris.
Chen JH; Zhang XG; Jiang YT; Yan LY; Tang L; Yin YW; Cheng DS; Chen J; Wang M
Cancer Immunol Immunother; 2010 Sep; 59(9):1335-45. PubMed ID: 20473755
[TBL] [Abstract][Full Text] [Related]
32. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity.
Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T
J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383
[TBL] [Abstract][Full Text] [Related]
33. Thymosin alpha1. SciClone Pharmaceuticals.
Billich A
Curr Opin Investig Drugs; 2002 May; 3(5):698-707. PubMed ID: 12090542
[TBL] [Abstract][Full Text] [Related]
34. Double-Controlled Release of Poorly Water-Soluble Paliperidone Palmitate from Self-Assembled Albumin-Oleic Acid Nanoparticles in PLGA in situ Forming Implant.
Yu Y; Ngo HV; Jin G; Tran PHL; Tran TTD; Nguyen VH; Park C; Lee BJ
Int J Nanomedicine; 2021; 16():2819-2831. PubMed ID: 33888982
[TBL] [Abstract][Full Text] [Related]
35. Preparation of sustained release microparticles with improved initial release property.
Jung GY; Na YE; Park MS; Park CS; Myung PK
Arch Pharm Res; 2009 Mar; 32(3):359-65. PubMed ID: 19387579
[TBL] [Abstract][Full Text] [Related]
36. In situ forming microparticle system for controlled delivery of leuprolide acetate: influence of the formulation and processing parameters.
Luan X; Bodmeier R
Eur J Pharm Sci; 2006 Feb; 27(2-3):143-9. PubMed ID: 16243496
[TBL] [Abstract][Full Text] [Related]
37. PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization.
Manca ML; Mourtas S; Dracopoulos V; Fadda AM; Antimisiaris SG
Colloids Surf B Biointerfaces; 2008 Apr; 62(2):220-31. PubMed ID: 18023977
[TBL] [Abstract][Full Text] [Related]
38. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
Liu SQ; Tong YW; Yang YY
Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
[TBL] [Abstract][Full Text] [Related]
39. The Effects of Lactidyl/Glycolidyl Ratio and Molecular Weight of Poly(D,L -Lactide-co-Glycolide) on the Tetracycline Entrapment and Release Kinetics of Drug-Loaded Nanofibers.
Yan N; Zhang X; Cai Q; Yang X; Zhou X; Wang B; Deng X
J Biomater Sci Polym Ed; 2012; 23(8):1005-19. PubMed ID: 21477461
[TBL] [Abstract][Full Text] [Related]
40. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J
Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
